Benzinga | Nov 9, 2020 04:19PM EST

Castle Biosciences Q3 EPS $(0.23) Misses $(0.11) Estimate, Sales $15.22M Beat $14.99M Estimate

Castle Biosciences (NASDAQ:CSTL) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.11) by 109.09 percent. This is a 1250 percent decrease over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $15.22 million which beat the analyst consensus estimate of $14.99 million by 1.51 percent. This is a 2.99 percent increase over sales of $14.78 million the same period last year.